Precigen Stock (NASDAQ: PGEN) stock price, news, charts, stock research, profile.
Open | $1.300 |
Close | $1.330 |
Volume / Avg. | 1.013M / 1.026M |
Day Range | 1.280 - 1.340 |
52 Wk Range | 0.835 - 1.880 |
Market Cap | $328.573M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 11.44% |
Days to Cover | 15.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Precigen (NASDAQ: PGEN) through any online brokerage.
Other companies in Precigen’s space includes: Renovaro (NASDAQ:RENB), Tevogen Bio Holdings (NASDAQ:TVGN), TScan Therapeutics (NASDAQ:TCRX), Monte Rosa Therapeutics (NASDAQ:GLUE) and FibroBiologics (NASDAQ:FBLG).
The latest price target for Precigen (NASDAQ: PGEN) was reported by JP Morgan on Friday, March 22, 2024. The analyst firm set a price target for 0.00 expecting PGEN to fall to within 12 months (a possible -100.00% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Precigen (NASDAQ: PGEN) is $1.32 last updated Today at April 19, 2024 at 5:21 PM EDT.
There are no upcoming dividends for Precigen.
Precigen’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Precigen.
Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.